Emergent BioSolutions chair receives RSUs and options
Emergent BioSolutions Inc. director and Chairman Zsolt Harsanyi received equity compensation in the form of restricted stock units and stock options.
Rhea-AI Filing Summary
Emergent BioSolutions Inc. director and Chairman Zsolt Harsanyi received equity compensation in the form of restricted stock units and stock options. He was granted 25,344 RSUs, each representing one share of common stock upon vesting, and 11,296 stock options with an exercise price of $7.99 per share. Both the RSUs and options vest on the day before the one-year anniversary of the grant date, contingent on his continued service on the board. Following these awards, Harsanyi directly holds 149,076 shares of Emergent BioSolutions common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 36,640 shares
Grant/Award
2 txns
Insider
Harsanyi Zsolt
Role
Chairman
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 11,296 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 25,344 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 11,296 contracts (Direct);
Common Stock — 149,076 shares (Direct)
Footnotes (3)
- F1. Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.
- F2. Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.
- F3. The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.
Key Figures
RSUs granted: 25,344 units
Stock options granted: 11,296 options
Option exercise price: $7.99 per share
+2 more
5 metrics
RSUs granted
25,344 units
Annual non-employee director grant on April 30, 2026
Stock options granted
11,296 options
Annual director option grant on April 30, 2026
Option exercise price
$7.99 per share
Exercise price for 11,296 stock options
Shares owned after grant
149,076 shares
Common stock directly held after RSU award
Underlying shares for options
11,296 shares
Common shares underlying new stock options
Key Terms
restricted stock units ("RSUs"), Stock Incentive Plan, Black-Scholes value, Annual Grant Vesting Date
4 terms
restricted stock units ("RSUs") financial
"Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Incentive Plan financial
"granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service"
A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.
Black-Scholes value financial
"dividing by the Black-Scholes value of a single option calculated as of the date of the grant"
Annual Grant Vesting Date financial
"will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date")"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Emergent BioSolutions (EBS) director Zsolt Harsanyi receive in this Form 4?
Zsolt Harsanyi received equity compensation consisting of 25,344 restricted stock units and 11,296 stock options. These awards reflect standard non-employee director compensation under Emergent BioSolutions’ stock incentive plan for board and committee service.
What are the vesting terms of the new RSUs reported for EBS director Harsanyi?
The 25,344 RSUs vest on the day prior to the one-year anniversary of the grant date. Vesting requires Harsanyi to remain a member of Emergent BioSolutions’ board of directors through that Annual Grant Vesting Date.
What are the key terms of the stock options granted to EBS director Harsanyi?
Harsanyi received 11,296 stock options, each allowing purchase of one EBS common share at an exercise price of $7.99. These options vest on the same Annual Grant Vesting Date, subject to his continued board service through that date.
How was the number of stock options for EBS director Harsanyi determined?
The option grant size was set by taking 25% of total non-employee director compensation value and dividing that amount by the Black-Scholes value of a single option calculated on the grant date, as disclosed in the footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
